Biopharmaceutical Drug Design and Development [electronic resource] / edited by Susanna Wu-Pong, Yon Rojanasakul.
| Call Number | 615 |
| Title | Biopharmaceutical Drug Design and Development edited by Susanna Wu-Pong, Yon Rojanasakul. |
| Edition | Second Edition. |
| Physical Description | X, 375 p. 30 illus., 3 illus. in color. online resource. |
| Contents | Biotechnology: 2008 and Beyond -- The Human Genome Project and Drug Development -- The Use of Bioinformatics and Chemogenomics in Drug Discovery -- DNA Microarrays in Drug Discovery and Development -- Microarray Technology Using Proteins, Cells, and Tissues -- Pharmacogenetic Issues in Biopharmaceutical Drug Development -- Development and Applications of Transgenics in Biotechnology and Medicine -- Viral, Nonviral, and Physical Methods for Gene Delivery -- Stem Cell Technology and Drug Development -- Small Nucleic Acid-Based Drugs: Successes and Pitfalls -- Therapeutic Strategies Targeting the Innate Antiviral Immune Response -- Pharmacogenetics in the Clinic -- Molecular Modeling: Considerations for the Design of Pharmaceuticals and Biopharmaceuticals -- Macromolecular Drug Delivery -- Changes in Biologic Drug Approval at FDA -- Follow-On Protein Products: The Age of Biogenerics?. |
| Summary | Biopharmaceutical Drug Design and Development, Second Edition, updates the widely successful first edition, published in 1999. This new, expanded edition investigates the dozens of new biopharmaceutical drugs that have become available since the publication of the first edition. Among the drugs discussed are ones in the categories of monoclonal antibodies for in-vivo use, cytokines, growth factors, enzymes, immunomodulators, thrombolytics, and immonotherapies including vaccines. Additionally, the volume examines new and emerging technologies, such as bioinformatics, DNA microarrays, transgenics, therapeutic gene delivery, stem cells, nucleic acid-based therapeutics, and macromolecular drug delivery. Authors also study pharmacogenetics in the clinic and changes in biologic drug approval at the FDA. Biopharmaceutical Drug Design and Development, Second Edition, is a worthy sequel in the discussion on the dynamic, exciting field of biotechnology. |
| Added Author | Wu-Pong, Susanna. editor. Rojanasakul, Yon. editor. SpringerLink (Online service) |
| Subject | MEDICINE. PHARMACY. PHARMACOLOGY. BIOCHEMISTRY. CELL BIOLOGY. Biomedicine. Pharmacology/Toxicology. Cell Biology. Biochemistry, general. Pharmacy. |
| Multimedia |
-
Libraries with this item
-
950 BiomedicalandLifeSciences(Springer-11642)
Total Ratings:
0
03504nam a22005295i 4500
001
vtls001568551
003
VRT
005
20170831183800.0
007
cr nn 008mamaa
008
170831s2008 xxu| s |||| 0|eng d
020
$a 9781597455329 $9 978-1-59745-532-9
024
7
$a 10.1007/978-1-59745-532-9 $2 doi
035
$a (DE-He213)978-1-59745-532-9
039
9
$y 201708311838 $z santha
050
4
$a RM1-950
072
7
$a MMG $2 bicssc
072
7
$a MED071000 $2 bisacsh
082
0
4
$a 615 $2 23
245
1
0
$a Biopharmaceutical Drug Design and Development $h [electronic resource] / $c edited by Susanna Wu-Pong, Yon Rojanasakul.
250
$a Second Edition.
264
1
$a Totowa, NJ : $b Humana Press, $c 2008.
300
$a X, 375 p. 30 illus., 3 illus. in color. $b online resource.
336
$a text $b txt $2 rdacontent
337
$a computer $b c $2 rdamedia
338
$a online resource $b cr $2 rdacarrier
347
$a text file $b PDF $2 rda
505
0
$a Biotechnology: 2008 and Beyond -- The Human Genome Project and Drug Development -- The Use of Bioinformatics and Chemogenomics in Drug Discovery -- DNA Microarrays in Drug Discovery and Development -- Microarray Technology Using Proteins, Cells, and Tissues -- Pharmacogenetic Issues in Biopharmaceutical Drug Development -- Development and Applications of Transgenics in Biotechnology and Medicine -- Viral, Nonviral, and Physical Methods for Gene Delivery -- Stem Cell Technology and Drug Development -- Small Nucleic Acid-Based Drugs: Successes and Pitfalls -- Therapeutic Strategies Targeting the Innate Antiviral Immune Response -- Pharmacogenetics in the Clinic -- Molecular Modeling: Considerations for the Design of Pharmaceuticals and Biopharmaceuticals -- Macromolecular Drug Delivery -- Changes in Biologic Drug Approval at FDA -- Follow-On Protein Products: The Age of Biogenerics?.
520
$a Biopharmaceutical Drug Design and Development, Second Edition, updates the widely successful first edition, published in 1999. This new, expanded edition investigates the dozens of new biopharmaceutical drugs that have become available since the publication of the first edition. Among the drugs discussed are ones in the categories of monoclonal antibodies for in-vivo use, cytokines, growth factors, enzymes, immunomodulators, thrombolytics, and immonotherapies including vaccines. Additionally, the volume examines new and emerging technologies, such as bioinformatics, DNA microarrays, transgenics, therapeutic gene delivery, stem cells, nucleic acid-based therapeutics, and macromolecular drug delivery. Authors also study pharmacogenetics in the clinic and changes in biologic drug approval at the FDA. Biopharmaceutical Drug Design and Development, Second Edition, is a worthy sequel in the discussion on the dynamic, exciting field of biotechnology.
650
0
$a MEDICINE.
650
0
$a PHARMACY.
650
0
$a PHARMACOLOGY.
650
0
$a BIOCHEMISTRY.
650
0
$a CELL BIOLOGY.
650
1
4
$a Biomedicine.
650
2
4
$a Pharmacology/Toxicology.
650
2
4
$a Cell Biology.
650
2
4
$a Biochemistry, general.
650
2
4
$a Pharmacy.
700
1
$a Wu-Pong, Susanna. $e editor.
700
1
$a Rojanasakul, Yon. $e editor.
710
2
$a SpringerLink (Online service)
773
0
$t Springer eBooks
776
0
8
$i Printed edition: $z 9781588297167
856
4
0
$u http://dx.doi.org/10.1007/978-1-59745-532-9
912
$a ZDB-2-SBL
950
$a Biomedical and Life Sciences (Springer-11642)
999
$a VIRTUA
No Reviews to Display
| Summary | Biopharmaceutical Drug Design and Development, Second Edition, updates the widely successful first edition, published in 1999. This new, expanded edition investigates the dozens of new biopharmaceutical drugs that have become available since the publication of the first edition. Among the drugs discussed are ones in the categories of monoclonal antibodies for in-vivo use, cytokines, growth factors, enzymes, immunomodulators, thrombolytics, and immonotherapies including vaccines. Additionally, the volume examines new and emerging technologies, such as bioinformatics, DNA microarrays, transgenics, therapeutic gene delivery, stem cells, nucleic acid-based therapeutics, and macromolecular drug delivery. Authors also study pharmacogenetics in the clinic and changes in biologic drug approval at the FDA. Biopharmaceutical Drug Design and Development, Second Edition, is a worthy sequel in the discussion on the dynamic, exciting field of biotechnology. |
| Contents | Biotechnology: 2008 and Beyond -- The Human Genome Project and Drug Development -- The Use of Bioinformatics and Chemogenomics in Drug Discovery -- DNA Microarrays in Drug Discovery and Development -- Microarray Technology Using Proteins, Cells, and Tissues -- Pharmacogenetic Issues in Biopharmaceutical Drug Development -- Development and Applications of Transgenics in Biotechnology and Medicine -- Viral, Nonviral, and Physical Methods for Gene Delivery -- Stem Cell Technology and Drug Development -- Small Nucleic Acid-Based Drugs: Successes and Pitfalls -- Therapeutic Strategies Targeting the Innate Antiviral Immune Response -- Pharmacogenetics in the Clinic -- Molecular Modeling: Considerations for the Design of Pharmaceuticals and Biopharmaceuticals -- Macromolecular Drug Delivery -- Changes in Biologic Drug Approval at FDA -- Follow-On Protein Products: The Age of Biogenerics?. |
| Subject | MEDICINE. PHARMACY. PHARMACOLOGY. BIOCHEMISTRY. CELL BIOLOGY. Biomedicine. Pharmacology/Toxicology. Cell Biology. Biochemistry, general. Pharmacy. |
| Multimedia |